These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2289573)

  • 1. [The clinical use of sodium hyaluronate eyedrops as a substitute for tears].
    He Z; Han S; Zhen Z; Ding X; Liang S
    Yan Ke Xue Bao; 1990 Dec; 6(3-4):111-2. PubMed ID: 2289573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders.
    Stuart JC; Linn JG
    Ann Ophthalmol; 1985 Mar; 17(3):190-2. PubMed ID: 3873200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium hyaluronate eyedrops enhance tear film stability.
    Hamano T; Horimoto K; Lee M; Komemushi S
    Jpn J Ophthalmol; 1996; 40(1):62-5. PubMed ID: 8739501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
    Jee D; Park M; Lee HJ; Kim MS; Kim EC
    J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of hyaluronic acid eyedrops in the treatment of dry eye. Cytologic study using an optical microscope and computerized microscope].
    Orsoni JG; Chiari M; Guazzi A; de Carli M; Guidolin D
    Ophtalmologie; 1988 Oct; 2(4):355-7. PubMed ID: 3247208
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of protective effects of sodium hyaluronate eyedrop against corneal epithelial disorders using an electrophysiological method.
    Araki R; Nakashima M; Teshima M; Owaki Y; Nakashima MN; Uematsu M; Kitaoka T; Nakamura T; Kitahara T; Sasaki H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):251-8. PubMed ID: 22324441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium hyaluronate ophthalmic solution on peripheral staining of rigid contact lens wearers.
    Itoi M; Kim O; Kimura T; Kanai A; Momose T; Kanki K; Yamaguchi T; Ueno Y; Kurokawa M; Komemushi S
    CLAO J; 1995 Oct; 21(4):261-4. PubMed ID: 8565197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca.
    Solomon A; Merin S
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):497-504. PubMed ID: 9867333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.
    Sand BB; Marner K; Norn MS
    Acta Ophthalmol (Copenh); 1989 Apr; 67(2):181-3. PubMed ID: 2658462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.
    Snibson GR; Greaves JL; Soper ND; Prydal JI; Wilson CG; Bron AJ
    Eye (Lond); 1990; 4 ( Pt 4)():594-602. PubMed ID: 2226990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium hyaluronate on diffuse epithelial keratitis after penetrating keratoplasty.
    Yokoi N; Yamada J; Nishida K; Kinoshita S
    Transplant Proc; 1995 Feb; 27(1):1412-3. PubMed ID: 7878929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Instillation of 0.1% hyaluronic acid in severe keratitis sicca].
    Tabatabay C
    J Fr Ophtalmol; 1985; 8(6-7):513. PubMed ID: 4078229
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viscosity-dependent fluid dynamics of eyedrops on the ocular surface.
    Shimmura S; Goto E; Shimazaki J; Tsubota K
    Am J Ophthalmol; 1998 Mar; 125(3):386-8. PubMed ID: 9512158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome.
    Ehrenberg M; Zolotariov E; Loeb E; Poliansky V; Levy A
    Curr Eye Res; 2015 Sep; 40(9):913-22. PubMed ID: 25329624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of corneal effect of different types of artificial tears in a simulated dry eye condition using a novel porcine dry eye model (pDEM).
    Choy EP; Cho P; Benzie IF; Choy CK
    Cornea; 2006 Dec; 25(10):1200-4. PubMed ID: 17172898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new lipid tear substitute in a mouse model of dry eye.
    Scifo C; Barabino S; De Pasquale G; Blanco AR; Mazzone MG; Rolando M
    Cornea; 2010 Jul; 29(7):802-6. PubMed ID: 20489574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus.
    Dogru M; Kaderli B; Gelisken O; Yücel A; Avci R; Goto E; Shimmura S; Shimazaki J; Tsubota K
    Am J Ophthalmol; 2004 Sep; 138(3):381-8. PubMed ID: 15364219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.